Grey biotechnology refers to the application of biotechnological processes and techniques in non-medical industries, often in the realms of environmental, agricultural, and industrial practices. Unlike the more familiar red, green, and white biotechnologies focused on healthcare, agriculture, and industry respectively, grey biotechnology navigates a broad spectrum of applications. This sector often involves the use of living organisms, cells, or biological systems to develop innovative solutions that address challenges in diverse fields. Examples include the use of microorganisms to remediate environmental pollutants, the development of biodegradable materials, and the enhancement of industrial processes through biological means. Grey biotechnology underscores the versatility of biotechnological advancements in contributing to sustainable and environmentally friendly practices across various sectors.
Title : Why do 90% of the drugs fail in development? An analysis of 82+ submissions; and a case study of immunotherapy
Narendra Chirmule, Indian Institute of Technology (IIT), India
Title : Eliminating implant failure in humans with nano chemistry: 45,000 cases and counting
Thomas J Webster, Brown University, United States
Title : Evaluating cell compatibility and subcutaneous host response of silk fibroin–chitosan plug composites as potential resorbable implants
Luis Jesus Villarreal Gomez, Universidad Autonoma de Baja California, Mexico
Title : Steps and strides: Cross-species insights into movement and injury
Babak Faramarzi, Western University of Health Sciences, United States
Title : Ancient wisdom, modern science: Biotech services transforming ayurveda
Prashant Sakharam Bhokardankar, Datta Meghe Ayurvedic Medical College Hospital and Research Centre, India
Title : Scientist’s computational lawyer
Julia Sidorova, Instituto Carlos III de Salud (CIBER-EHD), Spain